The ACE gene I/D polymorphism is not associated with generalized vitiligo susceptibility in Gujarat population

Pigment Cell and Melanoma Research

Volumn 21, Issue 3, 2008, Pages 407-408

  Dwivedi, Mitesh ^a   Laddha, Naresh C ^a   Shajil, E M ^a   Shah, Bela J ^b   Begum, Rasheedunnisa ^a  

^a M S UNIVERSITY OF BARODA   (India)

^b CIVIL HOSPITAL   (India)

Author keywords

ACE gene I D polymorphism; Autoimmunity; Vitiligo

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

AUTOIMMUNITY; CHROMOSOME 17Q; CONTROLLED STUDY; ENZYME ACTIVITY; GENE AMPLIFICATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN TISSUE; INDIA; INTRON; LETTER; NUCLEOTIDE SEQUENCE; VITILIGO;

GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDIA; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; REFERENCE STANDARDS; VITILIGO;

EID: 43549092403     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1755-148X.2008.00462.x     Document Type: Letter

References (13)

1. Akhtar, S., Gavalas, N.G., Gawkrodger, D.J., Watson, P.F., Weetman, A.P. Kemp, E.H. (2005). An insertion/deletion polymorphism in the gene encoding angiotensin converting enzyme is not associated with generalized vitiligo in an English population. Arch. Dermatol. Res. 297 (2 94 98.
2. Faul, F., Erdfelder, E., Lang, A.G. Buchner, A. (2007). G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav. Res. Methods, 39, 175 191.
3. Ishigami, T., Iwamoto, T., Tamura, K., Yamaguchi, S., Iwasawa, K., Uchino, K., Umemura, S. Ishii, M. (1995). Angiotensin I converting enzyme (ACE) gene polymorphism and essential hypertension in Japan. Ethnic difference of ACE genotype. Am. J. Hypertens. 8, 95 97.
4. Jin, S.Y., Park, H.H., Li, G.Z., Lee, H.J., Hong, M.S., Hong, S.J., Park, H.K., Chung, J.H. Lee, M.H. (2004). Association of angiotensin converting enzyme gene I/D polymorphism of vitiligo in Korean population. Pigment Cell Res. 17, 84 86.
5. Kemp, E.H., Waterman, E.A. Weetman, A.P. (2001). Immunological pathomechanisms in vitiligo. Expert Rev. Mol. Med. 3 (20 1 22.
6. Lee, E.J. (1994). Population genetics of the angiotensin-converting enzyme gene in Chinese. Br. J. Clin. Pharmacol. 37, 212 214.
7. Passeron, T. Ortonne, J.P. (2005). Physiopathology and genetics of vitiligo. J. Autoimmun. 25 ((Suppl. 1 63 68.
8. Rigat, B., Hubert, C., Alhenc-Getes, F., Cambien, F., Corvol, P. Soubrier, F. (1990). An insertion/deletion polymorphism in the angiotensin I converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 86, 1343 1346.
9. Scholzen, T.E., Stander, S., Riemann, H., Brzoska, T. Luger, T.A. (2003). Modulation of cutaneous inflammation by angiotensin converting enzyme. J. Immunol. 170, 3866 3873.
10. Shajil, E.M., Agrawal, D., Vagadia, K., Marfatia, Y.S. Begum, R. (2006). Vitiligo: clinical profiles in Vadodara, Gujarat. Ind. J. Dermatol. 51, 100 104.
11. Valia, A.K. Dutta, P.K. (1996). IADVL Text Book and Atlas of Dermatology Bombay : Bhalani Publishing House).
12. Vuk-Pavlovic, Z. Rohrbach, M.S. (1988). An in vitro model for the induction of angiotensin converting enzyme in sarcoidosis: possible parallels to the immune response. Clin. Exp. Immunol. 72, 499 504.
13. Zhang, X.J., Liu, J.B., Gui, J.P. et al. (2004). Characteristics of genetic epidemiology and genetic models for vitiligo. J. Am. Acad. Dermatol. 51, 383 390.